Table 3. Phenotypes associated with LTL and associated metabolites.
phenotype | beta [95%CI] | p | |
---|---|---|---|
telomere length | HDL cholesterol | 0.04 [0.02:0.06] | 2.50×10−6 |
eGFR | 1.42 [0.82:2.01] | 2.79×10−6 | |
smoking | −0.06 [−0.08:−0.03] | 3.17×10−5 | |
FEV1 | 0.03 [0.01:0.05] | 8.85×10−4 | |
1-palmitoylglycerophosphoinositol | SBP | 1.10 [0.52:1.67] | 1.76×10−4 |
GGT | 0.08 [0.03:0.12] | 1.04×10−3 | |
1-stearoylglycerophosphoinositol | SBP | 1.09 [0.56:1.61] | 5.34×10−5 |
4-vinylphenol sulfate | smoking | 0.24 [0.22:0.26] | 2.32×10−102 |
FEV1 | −0.02 [−0.04:−0.01] | 1.40×10−3 | |
gamma-glutamylphenylalanine | eGFR | −2.24 [−2.74:−1.73] | 3.14×10−18 |
GGT | 0.15 [0.10:0.19] | 3.21×10−12 | |
FEV1 | −0.03 [−0.05:−0.02] | 4.48×10−6 | |
HDL cholesterol | −0.03 [−0.05:−0.02] | 1.15×10−5 | |
ALAT | 0.10 [0.05:0.14] | 5.76×10−5 | |
gamma-glutamyltyrosine | GGT | 0.14 [0.10:0.19] | 5.41×10−11 |
eGFR | −1.65 [−2.19:−1.11] | 1.58×10−9 | |
ALAT | 0.11 [0.06:0.16] | 1.67×10−5 |